nurse and patient

Pelvital Announces Landmark Study Demonstrating Efficacy of Flyte® Device in Treating Stress Urinary Incontinence

Pelvital, the women’s health MedTech company on a mission to transform the standard of care for urinary incontinence, announced today the publication of its landmark paper “Randomized trial of mechanotherapy for the treatment of stress urinary incontinence in women” in the peer-reviewed journal Therapeutic Advances in Urology. The paper presents evidence of the efficacy of Pelvital’s novel, FDA-cleared device, Flyte, for the treatment of stress urinary incontinence (SUI) and weakened pelvic floor muscles, with results comparable to surgical intervention. Read more.

Source: PRNewsire, February 21, 2024

UroCure Expands SUI Sling Portfolio with the Nationwide Launch of the ArcSP and ArcTO Slings

UroCure and LiNA Medical USA are pleased to announce the nationwide launch of UroCure’s two latest innovations of surgical solutions for female stress urinary incontinence: the ArcSP Suprapubic Sling System and the ArcTO Transobturator Sling System.  These two additions complement the current UroCure ArcTV® Transvaginal Sling on the market. ArcSP will now provide a top-down, retropubic approach and ArcTO will accommodate surgeons that prefer an outside-in, transobturator approach. All three systems are based on AMS’ best-in-class slings, while incorporating UroCure’s laser cut sling with its patented stabilizing suture. The absorbable stabilizing suture is a key innovation of UroCure’s sling designed to maintain its open pore structure and to protect the sling from deformation during placement, tensioning, and sheath removal. Read more.

Source: PRNewswire, January 25, 2024

AUA/SUFU Updates Guideline on Surgical Treatment of Female Stress Urinary Incontinence

The American Urological Association (AUA) and the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU) has updated their 2017 clinical practice guideline on the surgical treatment of female stress urinary incontinence (SUI). This amendment is based on their review of 24 studies published through February 2022. No changes were made to the patient evaluation and cystoscopy and urodynamics testing sections and only a minor update was made to patient counseling. Read more.

Source: Renal and Urology News, June 16, 2023

AUA, SUFU Release an Amendment to the Female Stress Urinary Incontinence Guideline

Today, the American Urological Association (AUA), in partnership with the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU), released the 2023 clinical practice guideline amendment for the surgical treatment of female stress urinary incontinence (SUI).  SUI is a common problem experienced by many women. About 1 in 3 women suffer from SUI at some point in their lives, and the chance of having urinary incontinence increases with age. The updated guideline has 24 recommendations that provide a clinical framework for the assessment and treatment of SUI in women. Read more and access the new guideline.

Source: PRNewswire, April 25, 2023